Spinocerebellar Ataxia Type 11 Latest Advances
Find the Latest Research About Spinocerebellar Ataxia Type 11
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Missense variant in TTBK2 kinase domain causes loss of function and impaired protein phosphorylation.
Journal: Scientific reports
Published: July 04, 2025
A Novel TTBK2 Mutation in a Chinese Pedigree with Spinocerebellar Ataxia 11.
Journal: Cerebellum (London, England)
Published: October 05, 2023
Spinocerebellar ataxia type 11 (SCA11): TTBK2 variants, functions and associated disease mechanisms.
Spinocerebellar ataxia type 11 (SCA11): TTBK2 variants, functions and associated disease mechanisms.
Journal: Cerebellum (London, England)
Published: March 02, 2023
TTBK2 mutations associated with spinocerebellar ataxia type 11 disrupt peroxisome dynamics and ciliary localization of SHH signaling proteins.
Journal: bioRxiv : the preprint server for biology
Published: February 13, 2023
Spinocerebellar ataxia type 11 (SCA11): An update.
Journal: The European journal of neuroscience
Published: December 08, 2022
Adult onset pan-neuronal human tau tubulin kinase 1 expression causes severe cerebellar neurodegeneration in mice.
Journal: Acta neuropathologica communications
Published: September 10, 2020
Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11?
Journal: Parkinsonism & related disorders
Published: April 11, 2020
Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.
Journal: Cellular and molecular neurobiology
Published: January 27, 2020
The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor.
Journal: Acta crystallographica. Section F, Structural biology communications
Published: October 31, 2019
Phosphorylation of CEP83 by TTBK2 is necessary for cilia initiation.
Journal: The Journal of cell biology
Published: November 26, 2018
Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases.
Journal: European journal of medicinal chemistry
Published: September 07, 2018
Last Updated: 04/28/2026